Filing Details
- Accession Number:
- 0001209191-19-047421
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-26 17:07:05
- Reporting Period:
- 2019-08-22
- Accepted Time:
- 2019-08-26 17:07:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1290149 | Sierra Oncology Inc. | SRRA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1647647 | Barbara Klencke | C/O Sierra Oncology, Inc. 2150 885 West Georgia St. Vancouver A1 V6C 3E8 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-22 | 67,000 | $0.43 | 67,000 | No | 4 | P | Indirect | By spouse |
| Common Stock | Acquisiton | 2019-08-22 | 54,000 | $0.45 | 54,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-23 | 108,000 | $0.44 | 162,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By spouse |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price. The lowest price at which shares were purchased was $0.4375 and the highest price at which shares were purchased was $0.4399. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the range set forth herein.
Billionaire Hedge Funds
